Wall Street fluctuated as the country held riveted by former FBI director James Comey's public Senate testimony. When asked, Comey said he had "no doubt" that Russian government officials had attempted to interfere in the 2016 election. Valeant Pharmaceuticals (VRX) rose after agreeing to sell iNova Pharmaceuticals for $930 million in an all-cash deal. The deal is expected to close in the second half of the year. J.M. Smucker (SJM) was lower even after topping quarterly earnings estimates. Sales declined 1%, though did manage to come in higher than analysts' target. Nordstrom (JWN) led the S&P 500 after announcing that the retailer was exploring the possibility of a "going private transaction." The company's board has formed a special committee to weigh the option.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.